APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoposide Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Etoposide Soft Capsules Industry Growth and Trends Forecast to 2032

27 December 202592 pages

Choose your research edition.

Industry ResearchEtoposide Soft Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoposide Soft Capsules Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Etoposide Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoposide Soft Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoposide Soft Capsules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etoposide Soft Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Etoposide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Etoposide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Etoposide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Etoposide Soft Capsules include Jiangsu Hengrui Medicine, Xediton Pharmaceuticals, Taj Pharma, Nippon Kayaku and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Etoposide Soft Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Etoposide Soft Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Etoposide Soft Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Etoposide Soft Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Etoposide Soft Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Etoposide Soft Capsules Market by Company

Jiangsu Hengrui Medicine

Xediton Pharmaceuticals

Taj Pharma

Nippon Kayaku

Bristol-Myers Squibb

Etoposide Soft Capsules Segment by Type

25mg

50mg

Etoposide Soft Capsules Segment by Application

Malignant Lymphoma

Malignant Germ Cell Tumor

Small Cell Lung Cancer

Others

Etoposide Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoposide Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoposide Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoposide Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Etoposide Soft Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Etoposide Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg Table 2. Major Company of 50mg Table 3. Global Etoposide Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Etoposide Soft Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Etoposide Soft Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Etoposide Soft Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Etoposide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Etoposide Soft Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Etoposide Soft Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Etoposide Soft Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Etoposide Soft Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Etoposide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Etoposide Soft Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Etoposide Soft Capsules Industry Trends Table 25. Etoposide Soft Capsules Industry Drivers Table 26. Etoposide Soft Capsules Industry Opportunities and Challenges Table 27. Etoposide Soft Capsules Industry Restraints Table 28. Global Etoposide Soft Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Etoposide Soft Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Etoposide Soft Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Etoposide Soft Capsules Sales Share by Company (2021-2026) Table 32. Global Etoposide Soft Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Etoposide Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Etoposide Soft Capsules Major Company Production Sites and Headquarters Table 35. Global Etoposide Soft Capsules Company, Product Type & Application Table 36. Global Etoposide Soft Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Etoposide Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Etoposide Soft Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Etoposide Soft Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Etoposide Soft Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Etoposide Soft Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Etoposide Soft Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Etoposide Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Etoposide Soft Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Etoposide Soft Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Etoposide Soft Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Etoposide Soft Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Etoposide Soft Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Etoposide Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Etoposide Soft Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Etoposide Soft Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Etoposide Soft Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Etoposide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Etoposide Soft Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Etoposide Soft Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Etoposide Soft Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Etoposide Soft Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Etoposide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Etoposide Soft Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Jiangsu Hengrui Medicine Company Information Table 72. Jiangsu Hengrui Medicine Business Overview Table 73. Jiangsu Hengrui Medicine Etoposide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Jiangsu Hengrui Medicine Etoposide Soft Capsules Product Portfolio Table 75. Jiangsu Hengrui Medicine Recent Development Table 76. Xediton Pharmaceuticals Company Information Table 77. Xediton Pharmaceuticals Business Overview Table 78. Xediton Pharmaceuticals Etoposide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Xediton Pharmaceuticals Etoposide Soft Capsules Product Portfolio Table 80. Xediton Pharmaceuticals Recent Development Table 81. Taj Pharma Company Information Table 82. Taj Pharma Business Overview Table 83. Taj Pharma Etoposide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Taj Pharma Etoposide Soft Capsules Product Portfolio Table 85. Taj Pharma Recent Development Table 86. Nippon Kayaku Company Information Table 87. Nippon Kayaku Business Overview Table 88. Nippon Kayaku Etoposide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nippon Kayaku Etoposide Soft Capsules Product Portfolio Table 90. Nippon Kayaku Recent Development Table 91. Bristol-Myers Squibb Company Information Table 92. Bristol-Myers Squibb Business Overview Table 93. Bristol-Myers Squibb Etoposide Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bristol-Myers Squibb Etoposide Soft Capsules Product Portfolio Table 95. Bristol-Myers Squibb Recent Development Table 96. North America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Etoposide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 98. North America Etoposide Soft Capsules Sales Market Share by Country (2021-2026) Table 99. North America Etoposide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Etoposide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 101. North America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Etoposide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Etoposide Soft Capsules Market Share by Country (2021-2026) Table 104. North America Etoposide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Etoposide Soft Capsules Market Share Forecast by Country (2027-2032) Table 106. Europe Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Etoposide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 108. Europe Etoposide Soft Capsules Sales Market Share by Country (2021-2026) Table 109. Europe Etoposide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Etoposide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Etoposide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Etoposide Soft Capsules Market Share by Country (2021-2026) Table 114. Europe Etoposide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Etoposide Soft Capsules Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Etoposide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Etoposide Soft Capsules Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Etoposide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Etoposide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Etoposide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Etoposide Soft Capsules Market Share by Country (2021-2026) Table 124. Asia-Pacific Etoposide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Etoposide Soft Capsules Market Share Forecast by Country (2027-2032) Table 126. Latin America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Etoposide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 128. Latin America Etoposide Soft Capsules Sales Market Share by Country (2021-2026) Table 129. Latin America Etoposide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Etoposide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Etoposide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Etoposide Soft Capsules Market Share by Country (2021-2026) Table 134. Latin America Etoposide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Etoposide Soft Capsules Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Etoposide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Etoposide Soft Capsules Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Etoposide Soft Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Etoposide Soft Capsules Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Etoposide Soft Capsules Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Etoposide Soft Capsules Market Share by Country (2021-2026) Table 144. Middle East and Africa Etoposide Soft Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Etoposide Soft Capsules Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Etoposide Soft Capsules Distributors List Table 149. Etoposide Soft Capsules Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Etoposide Soft Capsules Image Figure 2. Global Etoposide Soft Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoposide Soft Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Etoposide Soft Capsules Sales (2021-2032) & (K Units) Figure 5. 25mg Image Figure 6. Global 25mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Etoposide Soft Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Etoposide Soft Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Etoposide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Etoposide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Etoposide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Etoposide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Etoposide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Etoposide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Etoposide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Etoposide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Etoposide Soft Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Etoposide Soft Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Etoposide Soft Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Malignant Lymphoma Image Figure 24. Global Malignant Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Malignant Germ Cell Tumor Image Figure 26. Global Malignant Germ Cell Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 27. Small Cell Lung Cancer Image Figure 28. Global Small Cell Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Etoposide Soft Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Etoposide Soft Capsules Market Share by Application 2025 VS 2032 Figure 33. North America Etoposide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 34. North America Etoposide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 35. Europe Etoposide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Europe Etoposide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Etoposide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Etoposide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 39. Latin America Etoposide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Etoposide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Etoposide Soft Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Etoposide Soft Capsules Sales Market Share in Value by Application in 2025 Figure 43. North America Etoposide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Etoposide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Etoposide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Etoposide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Etoposide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Etoposide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Etoposide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Etoposide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Etoposide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Etoposide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Etoposide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Etoposide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Etoposide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Etoposide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Etoposide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Etoposide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Etoposide Soft Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Etoposide Soft Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Etoposide Soft Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Etoposide Soft Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Etoposide Soft Capsules Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Etoposide Soft Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Malignant Lymphoma
  • Malignant Germ Cell Tumor
  • Small Cell Lung Cancer
  • Others
Companies covered
  • Jiangsu Hengrui Medicine
  • Xediton Pharmaceuticals
  • Taj Pharma
  • Nippon Kayaku
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Etoposide Soft Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Etoposide Soft Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Etoposide Soft Capsules Market by Type
  6. 1.3.1 25mg
  7. 1.3.2 50mg
  8. 1.4 Global Etoposide Soft Capsules Market Size by Type
  9. 1.4.1 Global Etoposide Soft Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Etoposide Soft Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Etoposide Soft Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Etoposide Soft Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Etoposide Soft Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Etoposide Soft Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Etoposide Soft Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Etoposide Soft Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Etoposide Soft Capsules Industry Trends
  2. 2.2 Etoposide Soft Capsules Industry Drivers
  3. 2.3 Etoposide Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Etoposide Soft Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Etoposide Soft Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Etoposide Soft Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Etoposide Soft Capsules Price (2021-2026)
  4. 3.4 Global Etoposide Soft Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Etoposide Soft Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Etoposide Soft Capsules Company, Product Type & Application
  7. 3.7 Global Etoposide Soft Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Etoposide Soft Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Etoposide Soft Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Etoposide Soft Capsules Tier 1, Tier 2, and Tier 3
4 Etoposide Soft Capsules Regional Status and Outlook
  1. 4.1 Global Etoposide Soft Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Etoposide Soft Capsules Historic Market Size by Region
  3. 4.2.1 Global Etoposide Soft Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Etoposide Soft Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Etoposide Soft Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Etoposide Soft Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Etoposide Soft Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Etoposide Soft Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Etoposide Soft Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Etoposide Soft Capsules by Application
  1. 5.1 Etoposide Soft Capsules Market by Application
  2. 5.1.1 Malignant Lymphoma
  3. 5.1.2 Malignant Germ Cell Tumor
  4. 5.1.3 Small Cell Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Etoposide Soft Capsules Market Size by Application
  7. 5.2.1 Global Etoposide Soft Capsules Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Etoposide Soft Capsules Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Etoposide Soft Capsules Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Etoposide Soft Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Etoposide Soft Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Etoposide Soft Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Etoposide Soft Capsules Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Etoposide Soft Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jiangsu Hengrui Medicine
  2. 6.1.1 Jiangsu Hengrui Medicine Company Information
  3. 6.1.2 Jiangsu Hengrui Medicine Business Overview
  4. 6.1.3 Jiangsu Hengrui Medicine Etoposide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jiangsu Hengrui Medicine Etoposide Soft Capsules Product Portfolio
  6. 6.1.5 Jiangsu Hengrui Medicine Recent Developments
  7. 6.2 Xediton Pharmaceuticals
  8. 6.2.1 Xediton Pharmaceuticals Company Information
  9. 6.2.2 Xediton Pharmaceuticals Business Overview
  10. 6.2.3 Xediton Pharmaceuticals Etoposide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xediton Pharmaceuticals Etoposide Soft Capsules Product Portfolio
  12. 6.2.5 Xediton Pharmaceuticals Recent Developments
  13. 6.3 Taj Pharma
  14. 6.3.1 Taj Pharma Company Information
  15. 6.3.2 Taj Pharma Business Overview
  16. 6.3.3 Taj Pharma Etoposide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taj Pharma Etoposide Soft Capsules Product Portfolio
  18. 6.3.5 Taj Pharma Recent Developments
  19. 6.4 Nippon Kayaku
  20. 6.4.1 Nippon Kayaku Company Information
  21. 6.4.2 Nippon Kayaku Business Overview
  22. 6.4.3 Nippon Kayaku Etoposide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nippon Kayaku Etoposide Soft Capsules Product Portfolio
  24. 6.4.5 Nippon Kayaku Recent Developments
  25. 6.5 Bristol-Myers Squibb
  26. 6.5.1 Bristol-Myers Squibb Company Information
  27. 6.5.2 Bristol-Myers Squibb Business Overview
  28. 6.5.3 Bristol-Myers Squibb Etoposide Soft Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Etoposide Soft Capsules Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America Etoposide Soft Capsules Sales by Country
  2. 7.1.1 North America Etoposide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Etoposide Soft Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Etoposide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Etoposide Soft Capsules Market Size by Country
  6. 7.2.1 North America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Etoposide Soft Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Etoposide Soft Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Etoposide Soft Capsules Sales by Country
  2. 8.1.1 Europe Etoposide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Etoposide Soft Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Etoposide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Etoposide Soft Capsules Market Size by Country
  6. 8.2.1 Europe Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Etoposide Soft Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Etoposide Soft Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Etoposide Soft Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Etoposide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Etoposide Soft Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Etoposide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Etoposide Soft Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Etoposide Soft Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Etoposide Soft Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Etoposide Soft Capsules Sales by Country
  2. 10.1.1 South America Etoposide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Etoposide Soft Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Etoposide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Etoposide Soft Capsules Market Size by Country
  6. 10.2.1 South America Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Etoposide Soft Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Etoposide Soft Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Etoposide Soft Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Etoposide Soft Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Etoposide Soft Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Etoposide Soft Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Etoposide Soft Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Etoposide Soft Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Etoposide Soft Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Etoposide Soft Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Etoposide Soft Capsules Value Chain Analysis
  2. 12.1.1 Etoposide Soft Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Etoposide Soft Capsules Production Mode & Process
  7. 12.2 Etoposide Soft Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Etoposide Soft Capsules Distributors
  10. 12.2.3 Etoposide Soft Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst